Profile: PDI Inc (PDII.OQ)
4.76USD
1 Aug 2013
$0.11 (+2.37%)
$4.65
$4.71
$4.78
$4.71
5,946
23,000
$8.25
$3.82
PDI, Inc. provides outsourced commercial services to established and emerging pharmaceutical, biotechnology and healthcare companies in the United States. The Company is a provider of outsourced sales teams that focus on healthcare providers, offering a range of complementary sales support services designed to achieve its customers' strategic and financial product objectives. In addition to outsourced sales teams, it also provides other promotional services, including clinical educator services, digital communications, teledetailing and with the formation of its new business unit on August 1, 2011, Interpace BioPharma, provides pharmaceutical, biotechnology, medical device and diagnostics clients with full-service product commercialization solutions. The Company has three segments: Sales Services; Marketing Services and Product Commercialization Services (PC Services). On March 3, 2011, it announced the launch of a new business unit within its Sales Services segment, EngageCE, which provides clinical educator services to its customers.
Interpace BioPharma services include full supply chain management, operations, sales, marketing, compliance, and regulatory/medical management. The Company has designed and implemented programs for many pharmaceutical companies, a range of emerging and specialty pharmaceutical and biotechnology companies, as well as nutritional, diagnostic and other healthcare service providers.
Sales Services (Personal Promotion)
The Company’s Sales Services segment focuses primarily on product detailing, includes its outsourced sales teams and a new business unit, EngageCE. During the year ended December 31, 2011, Sales Services segment 86% of its consolidated revenue. Sales Services segment also includes a portfolio of expanded sales services, which includes talent acquisition services, short-term teams and vacancy coverage services. Its talent acquisition platform provides pharmaceutical customers with an outsourced, stand-alone sales force recruiting and on-boarding service. Short-term programs provide temporary full or flex-time sales teams, and are designed to help the customers increase brand impact during key market cycles, rapidly respond to regional opportunities, or conduct pilot programs. The Company's vacancy coverage service provides customers with outsourced full or flex-time sales representatives to fill PDI, Inc.
The Company's Shared Sales Teams business model centers on an existing PDI-managed team where multiple non-competing brands are promoted for different pharmaceutical companies. Using these teams, it makes a face-to-face selling resource available to those customers who want an alternative to a Dedicated Sales Team. The Company is a provider of this type of detailing program in the United States. EngageCE offers clinical educators to work with health care providers in the management of chronic diseases in order to optimize patient care and outcomes.
Marketing Services (Non-personal Promotion)
The Company’s Marketing Services segment includes two business units: Group DCA and PDI Voice (Voice). The Marketing Services segment represented 8% of consolidated revenue during 2011. On December 29, 2011, the Company sold certain assets of its Pharmakon business unit and classified Pharmakon as discontinued operations. The Company does not have continuing operations in these disposed business units. Group DCA's business is focused on the creation, design and implementation of interactive digital communications, including its e-detailing programs to the healthcare community on behalf of its pharmaceutical, biotechnology and healthcare customers. Group DCA leverages the strength of the Internet, multimedia, tablet personal computers, mobile devices, dimensional direct mail and its software, DIAGRAM (DIAlog, GRAphics, Motion), to deliver digital selling solutions through interactive communications exchanges that accommodate the schedules of healthcare providers.
Voice's business is focused on the creation of teledetailing programs that are executed through the Company's tele-representatives. Voice programs are designed to cover healthcare providers that are either categorized as no see, who are geographically not covered by the customer's sales team or where a vacancy within the team exists. In addition to teledetailing programs, the Company's call center can provide program enrollment support, conduct telephonic surveys and manage sample, literature and other materials fulfillment requests by healthcare providers.
Product Commercialization Services (PC Services)
Interpace BioPharma provides pharmaceutical, biotechnology, medical device and diagnostics clients with full-service product commercialization solutions. These services include product detailing, full supply chain management, operations, sales, marketing, compliance, and regulatory/medical management. The PC Services segment represented 6% of consolidated revenue during 2011.
The Company competes with Ventiv Health Inc., Quintiles, Publicis Touchpoint Solutions, WebMD, Inc., Cadient Group, Inc., Heartbeat Digital and Digitas, Inc.
Company Address
PDI Inc
Morris Corporate Center 1
Building A, 300 Interpace Parkwa
PARSIPPANY NJ 07054
P: +1862.2077800
F: +1302.6745266
Company Web Links
| Name | Compensation |
|---|---|
Gerald Belle |
-- |
Nancy Lurker |
1,377,040 |
Jeffrey Smith |
738,361 |
Gerald Melillo |
-- |
Jo Saitta |
448,775 |

